Reply to: Huang et al

Affiliations

¹ Department of Respiratory Medicine, National Hospital Organization Fukuoka National Hospital, Fukuoka, Japan.
² Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; and.
³ Firestone Institute for Respiratory Health, Research Institute at St Joseph's Healthcare, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

Comment

Toyoshi Yanagihara et al. Am J Respir Crit Care Med. 2023.

. 2023 Dec 1;208(11):1242-1243.

doi: 10.1164/rccm.202309-1562LE.

¹ Department of Respiratory Medicine, National Hospital Organization Fukuoka National Hospital, Fukuoka, Japan.
² Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; and.
³ Firestone Institute for Respiratory Health, Research Institute at St Joseph's Healthcare, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

No abstract available

Comment on

Tacrolimus and the Treatment of Pulmonary Fibrosis.
Huang D, Li Y, Liu Y. Huang D, et al. Am J Respir Crit Care Med. 2023 Dec 1;208(11):1241-1242. doi: 10.1164/rccm.202308-1445LE. Am J Respir Crit Care Med. 2023. PMID: 37699242 Free PMC article. No abstract available.

1. Yanagihara T, Tsubouchi K, Zhou Q, Chong M, Otsubo K, Isshiki T, et al. Vascular-parenchymal cross-talk promotes lung fibrosis through BMPR2 signaling. Am J Respir Crit Care Med . 2023;207:1498–1514. - PubMed
1. Xu B, Xu G, Yu Y, Lin J. The role of TGF-β or BMPR2 signaling pathway-related miRNA in pulmonary arterial hypertension and systemic sclerosis. Arthritis Res Ther . 2021;23:288. - PMC - PubMed
1. Kiboshi T, Kotani T, Konma J, Makino H, Matsuda S, Suzuka T, et al. Comparison of therapeutic effects of combination therapy with prednisolone and tacrolimus or azathioprine on progressive interstitial pneumonia with systemic sclerosis. Mod Rheumatol. 2022;32:358–364. - PubMed
1. Spiekerkoetter E, Tian X, Cai J, Hopper RK, Sudheendra D, Li CG, et al. FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension. J Clin Invest . 2013;123:3600–3613. - PMC - PubMed
1. Hofmann NN, Ambühl RA, Jordan S, Distler O. Calcineurin inhibitors in systemic sclerosis: a systematic literature review. Ther Adv Musculoskelet Dis . 2022;14:1759720X221092374. - PMC - PubMed